EDGEMOND JAMES sold UTHR
December 1, 2025 · Form 4 insider transaction
EDGEMOND JAMES sold 160 shares of United Therapeutics Corporation at $484.68 per share, a transaction worth $77.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
160
Price
$484.68
Total value
$77.5K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 1, 2025
Filing dateDecember 2, 2025
Shares owned after8,142
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.